Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirent Regulatory News (SPT)

Share Price Information for Spirent (SPT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 183.00
Bid: 182.80
Ask: 183.10
Change: -0.20 (-0.11%)
Spread: 0.30 (0.164%)
Open: 184.00
High: 184.00
Low: 181.90
Prev. Close: 183.20
SPT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Spirent Communications Plc

25 Jun 2024 11:12

RNS Number : 8000T
UBS AG (EPT)
25 June 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

UBS Investment Bank, London

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Spirent Communications plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Spirent Communications plc

(d) Date dealing undertaken:

24 June 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

3 1/3p ordinary

Buy

 

41828

1.86701 GBP

1.84396 GBP

3 1/3p ordinary

Sell

 

37080

1.85903 GBP

1.84396 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

25 June 2024

Contact name:

Richard Howard

Telephone number:

+44 (0)207 568 9128

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERPPUGGQUPCGUA
Date   Source Headline
4th Aug 20227:00 amRNSResults for the six months ended 30 June 2022
1st Aug 20229:16 amRNSTotal Voting Rights
26th Jul 20229:54 amRNSDirector/PDMR Shareholding
4th Jul 20229:21 amRNSBlock listing Interim Review
1st Jul 20229:04 amRNSTotal Voting Rights
28th Jun 202210:11 amRNSNotice of 2022 Half Year Results Presentation
27th Jun 202212:14 pmRNSDirector/PDMR Shareholding
21st Jun 20224:45 pmRNSDirector Declaration
1st Jun 20228:33 amRNSTotal Voting Rights
25th May 20222:04 pmRNSDirector/PDMR Shareholding
23rd May 20223:49 pmRNSDirector/PDMR Shareholding
19th May 20221:20 pmRNSDirector/PDMR Shareholding
19th May 202212:50 pmRNSDirector/PDMR Shareholding
19th May 202212:38 pmRNSHolding(s) in Company
13th May 20223:02 pmRNSDirector/PDMR Shareholding
12th May 202212:30 pmRNSDirector Declaration
11th May 202212:03 pmRNSDirector/PDMR Shareholding
6th May 20224:51 pmRNSResult of AGM
6th May 20227:00 amRNSStrong Momentum Continues
5th May 20223:30 pmRNSDirector/PDMR Shareholding
5th May 20221:47 pmRNSHolding(s) in Company
4th May 20224:29 pmRNSAnnual General Meeting 2022
3rd May 20228:44 amRNSTotal Voting Rights
26th Apr 202210:50 amRNSDirector/PDMR Shareholding
1st Apr 20228:37 amRNSTotal Voting Rights
30th Mar 20221:53 pmRNSAnnual Report 2021 and Associated Documents
25th Mar 202212:24 pmRNSDirector/PDMR Shareholding
17th Mar 20225:06 pmRNSDirector/PDMR Shareholding
17th Mar 20222:45 pmRNSHolding(s) in Company
11th Mar 202210:52 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSFull Year Results
3rd Mar 20225:11 pmRNSHolding(s) in Company
1st Mar 20228:36 amRNSTotal Voting Rights
25th Feb 202210:09 amRNSDirector/PDMR Shareholding
1st Feb 20228:40 amRNSTotal Voting Rights
31st Jan 20229:00 amRNSNotice of 2021 Full Year Results Presentation
25th Jan 20221:04 pmRNSDirector/PDMR Shareholding
20th Jan 20227:00 amRNSTrading Update 2021
4th Jan 20221:40 pmRNSBlock listing Interim Review
4th Jan 20229:07 amRNSTotal Voting Rights
29th Dec 202112:09 pmRNSDirector/PDMR Shareholding
1st Dec 20218:55 amRNSTotal Voting Rights
25th Nov 202111:40 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSThird Quarter 2021 Trading Update
1st Nov 20218:36 amRNSTotal Voting Rights
26th Oct 20219:10 amRNSDirector/PDMR Shareholding
1st Oct 20218:52 amRNSTotal Voting Rights
30th Sep 202111:11 amRNSHolding(s) in Company
27th Sep 20219:39 amRNSDirector/PDMR Shareholding
21st Sep 20212:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.